Ebit Zmiana Data
Adma Biologics USD 62.75M 13.56M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Novavax USD 20.94M 100.32M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Takeda JPY 257.49B 568.56B 2025-12